Filter Results:
(4,656)
Show Results For
- All HBS Web
(4,656)
- People (16)
- News (1,870)
- Research (2,248)
- Events (2)
- Multimedia (220)
- Faculty Publications (1,833)
Show Results For
- All HBS Web
(4,656)
- People (16)
- News (1,870)
- Research (2,248)
- Events (2)
- Multimedia (220)
- Faculty Publications (1,833)
- September 2009
- Case
The Risk Management Foundation of the Harvard Medical Institutions, Inc.
By: Richard M.J. Bohmer, Stephen P. Bradley and Natalie Kindred
Through its uniquely proactive approach to medical malpractice risk management, the Risk Management Foundation (RMF) has decreased claims—and premiums—for the Harvard hospitals it insures. The RMF is the captive medico-legal insurer of the Harvard medical institutions... View Details
Keywords: Cost Management; Insurance; Health Care and Treatment; Risk Management; Performance Improvement; Safety; Health Industry; Health Industry; Boston
Bohmer, Richard M.J., Stephen P. Bradley, and Natalie Kindred. "The Risk Management Foundation of the Harvard Medical Institutions, Inc." Harvard Business School Case 610-014, September 2009.
Joey Ryu
Joey (Won Jung) Ryu is a doctoral student in the Strategy unit at Harvard Business School. Her primary interests are strategic management, economics of innovation and entrepreneurship. Prior to joining HBS, Joey received her master's degree from Cornell University... View Details
- March 2023 (Revised March 2023)
- Case
Roche: Innovation and Access to Healthcare
By: George Serafeim, Susanna Gallani and Benjamin Maletta
In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that had... View Details
Keywords: ESG (Environmental, Social, Governance) Performance; Sustainable Finance; Growth Strategy And Execution; Sustainability Targets; Impact Evaluation; Healthcare Access; Healthcare Innovation; Healthcare Systems; Healthcare Operations; Finance; Strategy; Health Testing and Trials; Health Care and Treatment; Growth Management; Measurement and Metrics; Innovation Strategy; Corporate Social Responsibility and Impact; Health Industry; Health Industry; Switzerland; North America; Europe; Asia; Latin America; Africa
Serafeim, George, Susanna Gallani, and Benjamin Maletta. "Roche: Innovation and Access to Healthcare." Harvard Business School Case 123-075, March 2023. (Revised March 2023.)
- 31 Jan 2014
- Working Paper Summaries
The Diseconomies of Queue Pooling: An Empirical Investigation of Emergency Department Length of Stay
- 16 Jan 2013
- Research & Ideas
The Messy Link Between Slave Owners and Modern Management
it was also built on the backs of slaves who were literally the opposite of free. "It's a much bigger, more powerful question to ask, If today we are using management techniques that were also used on slave plantations," she says, "how much more View Details
Keywords: by Katie Johnston
- 22 Feb 2023
- Blog Post
Meet the Disability Advocacy and Affinity Group (DAAG)
The Disability Advocacy and Affinity Group (DAAG)) has a mission to destigmatize the experience of living with or being the caretaker of someone with a disability. We cherish the unique perspectives that individuals with disabilities bring to every academic,... View Details
- Web
Faculty & Researchers - Managing the Future of Work
related to the workforce, including the skills gap, degree inflation, care economics, the role of artificial intelligence in employment outcomes, the effectiveness of social entrepreneurs in improving education to employment outcomes,... View Details
- 06 Oct 2008
- Research & Ideas
Updating a Classic: Writing a Great Business Plan
which has a negative effect on all ventures, sensible and nonsensical. I would also reinforce the idea that entrepreneurship is critical around the world. We are confronted with many crises from health care... View Details
Keywords: by Sean Silverthorne
- 16 Mar 2020
- Research & Ideas
How the Coronavirus Is Already Rewriting the Future of Business
With COVID-19 cases growing worldwide, business leaders are scrambling to deal with a wide variety of problems, from slumping sales and stalling supply chains to keeping employees healthy and making sure they can continue working. We asked professors of Harvard... View Details
Keywords: by Dina Gerdeman
- January 2024
- Article
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Objective: To estimate Medicare spending and global... View Details
Vogel, Matthew, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, and Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation." JAMA Internal Medicine 184, no. 1 (January 2024): 63–69.
- 25 Mar 2021
- Blog Post
Meet the Student Academic Services Support Team at HBS!
the myriad social and co-curricular opportunities available during their time here. So how can they help? The MBA Student & Academic Services Support Services team provides direct support, counseling, and advising to all HBS students on academic and personal... View Details
- 21 Aug 2000
- Research & Ideas
Inside the OR: Disrupted Routines and New Technologies
technologies. Successful teams in the study led open and deliberate efforts to expand the boundary of MICS awareness into related areas of the hospital such as the cardiology and intensive care units. A nurse described her role, "We... View Details
Keywords: by Hilah Geer
- 30 Mar 2021
- Research & Ideas
Commuting Hurts Productivity and Your Best Talent Suffers Most
negative health outcomes, including heart disease—Wu says this is the first study to analyze the impact on the innovation generated by firms and their workers. The research team analyzed a sample of 3,445 inventors and 1,180 firms in... View Details
Keywords: by Lane Lambert
- October 2022
- Case
Cost Plus Drugs
By: Alexander MacKay and James Barnett
In September 2022, Mark Cuban Cost Plus Drugs Company CEO Alex Oshmyansky considered the future of the company. Cost Plus Drugs was a retailer for more than 340 generic oral medications, selling their drugs at significantly lower prices than typical pharmacies.... View Details
Keywords: Business Ventures; Decision Making; Entrepreneurship; Ethics; Health; Markets; Social Enterprise; Society; Strategy; Health Care and Treatment; Business Divisions; Factories, Labs, and Plants; Health Industry; Health Industry; United States; Texas
MacKay, Alexander, and James Barnett. "Cost Plus Drugs." Harvard Business School Case 723-362, October 2022.
- 16 Jul 2020
- Research & Ideas
Restaurant Revolution: How the Industry Is Fighting to Stay Alive
policies with exclusions. Thanks, but no thanks to bailouts Our panelists expressed frustration with government aid programs, such as the US CARES Act and its Paycheck Protection Program (PPP) enacted in late March. Although designed to... View Details
- 03 Dec 2021
- Blog Post
Physicians Off the Beaten Path
Youssef is a medical doctor and the first Syrian Rhodes Scholar. He has an MD from Syria, an MSc in International Health at Oxford and is currently doing an MBA at Harvard Business School along with a PhD in computer science (clinical AI)... View Details
Alvin E. Roth
Al Roth is the George Gund Professor of Economics and Business Administration in the Department of Economics at Harvard University, and in the Harvard Business School. His research, teaching, and consulting interests are in game theory, experimental economics, and... View Details
- October 2009
- Case
Medisys Corp.: The IntensCare Product Development Team
By: Anne Donnellon and Joshua D. Margolis
Key topics include designing teams, managing teams, managing conflict, group dynamics, project management, product development, interdepartmental relations, and organizational change. MediSys, a U.S.-based medical equipment maker, has been developing IntensCare, a new... View Details
Keywords: Project Management; Interdepartmental Relations; Organizational Change; Leadership; Conflict Management; Interpersonal Communication; Groups and Teams; Product Design; Product Development; Organizational Change and Adaptation; Health Care and Treatment; Power and Influence; Medical Devices and Supplies Industry; United States
Donnellon, Anne, and Joshua D. Margolis. "Medisys Corp.: The IntensCare Product Development Team." Harvard Business School Brief Case 094-059, October 2009.
- Web
News - Institute For Strategy And Competitiveness
Military Providers Course. The new IPU brings together a diverse team. November 2019 Media Mention Value-Based Care in Low and Middle Income Nations Value-Based Care in Low and Middle Income Nations The... View Details